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Activation of NADPH oxidase by purine and pyrimidine
nucleotides involves G proteins and is potentiated by chemotactic
peptides
Roland SEIFERT,* Rahel BURDE and Giinter SCHULTZ
Institut fur Pharmakologie, Freie Universitat Berlin, Thielallee 69/73, D-1000 Berlin 33, Federal Republic of Germany
Human neutrophils and HL-60 leukaemic cells possess an NADPH oxidase which catalyses superoxide (02-)
formation and is activated by the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine
(fMet-Leu-Phe). In dibutyryl cyclic AMP-differentiated HL-60 cells, ATP and UTP in the presence of
cytochalasin B activated 02- formation with EC50 values of 5 /LM and efficacies amounting to 3000
of that of fMet-Leu-Phe. The potency order of purine nucleotides in activating 02- generation was
ATP = adenosine 5'-O-(3-thiotriphosphate) > ITP > dATP = ADP. Pyrimidine nucleotides activated
NADPH oxidase in the potency order UTP > dUTP> CTP = TTP = UDP. Pertussis toxin completely
prevented activation of NADPH oxidase by fMet-Leu-Phe and UTP, whereas the effect of ATP was only
partially inhibited. ATP and UTP enhanced 02- generation induced by fMet-Leu-Phe by up to 8-fold, and
primed the cells to respond to non-stimulatory concentrations of fMet-Leu-Phe. Activation of NADPH
oxidase by UTP but not by ATP was inhibited by various activators of adenylate cyclase. In dimethyl
sulphoxide-differentiated HL-60 cells and in human neutrophils, ATP and UTP per se did not activate
NADPH oxidase, but they potentiated the effect of fMet-Leu-Phe. Our results suggest that purine and
pyrimidine nucleotides act via purino- and novel pyrimidinoceptors respectively, which are coupled to
guanine nucleotide-binding proteins leading to the activation of NADPH oxidase. As ATP and UTP are
released from cells under physiological and pathological conditions, these nucleotides may play roles as
intercellular signal molecules in the activation of 02- formation.
INTRODUCTION
Human neutrophils and HL-60 leukaemic cells possess
an NADPH oxidase which catalyses superoxide (02-)
generation and is activated by the chemotactic peptide,
N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-
Leu-Phe) (McPhail & Snyderman, 1984; Rossi, 1986).
Formyl peptide receptors interact with guanine
nucleotide-binding proteins (G proteins) leading to the
activation of phospholipase C, which catalyses the
degradation of polyphosphoinositides to inositol
phosphates and diacylglyerol (Lad et al., 1985a; Ohta
et al., 1985). ADP-ribosylation of the G proteins by
pertussis toxin prevents cell activation (Lad et al., 1985a;
Ohta et al., 1985; Gierschik et al., 1987; Gilman, 1987).
The mechanism by which chemotactic peptides activate
NADPH oxidase has been suggested to involve protein
kinase C, as cell-permeable diacylglycerol and phorbol
myristate acetate are stimulators of protein kinase C and
of 02- generation (McPhail & Snyderman, 1984; Rossi,
1986). However, we and others have recently provided
evidence that activation of NADPH oxidase involves
more direct regulation by G proteins (Seifert et al., 1986,
1988; Seifert & Schultz, 1987a,b; Gabig et al., 1987).
Under physiological and pathological conditions,
nucleoside triphosphates are released into the extra-
cellular space from a variety of cell types (Goetz et al.,
1971; Shirasawa et al., 1983; Gordon, 1986; Hardebo
et al., 1987; Forsberg et al., 1987). Released ATP binds
to purinoceptors which regulate many cell functions
(Burnstock & Kennedy, 1985; Gordon, 1986). Purino-
ceptors can be classified into subtypes according to the
potency of purinergic agonists. Recently, ATP was
reported to activate phospholipase C in HL-60 cells
(Dubyak et al., 1987). In addition, ATP induces an
increase in the intracellular Ca2" concentration in human
neutrophils and enhances fMet-Leu-Phe-induced 02-
formation (Kuhns et al., 1988). Not only ATP but also
UTP plays a role as modulator of cellular functions
(Mustard & Packham, 1970; Shirasawa et al., 1983;
Dubyak & DeYoung, 1985; Forsberg et al., 1987;
Hardebo et al., 1987; Kiugelen et al., 1987; Haussinger
et al., 1987). There is recent evidence that UTP does not
mediate its effects via purinoceptors (Kiugelen et al.,
1987; Haussinger et al., 1987). These findings prompted
us to study the role of purine and pyrimidine nucleotides
in the regulation of NADPH oxidase. We report here
that ATP and UTP act on purino- and putative
pyrimidinoceptors in HL-60 cells and in human
neutrophils to activate NADPH oxidase via G proteins.
MATERIALS AND METHODS
Materials
N-t-Butoxycarbonyl-L-phenylalanyl-L-leucyl-L-
phenylalanyl-L-leucyl-L-phenylalanine, prostaglandin E1,
isoproterenol, cholera toxin, 5'-N-ethylcarboxamido-
adenosine, a,,-methylene-ATP, uridine, uridyl(3'-5')-
* To whom reprint requests should be sent.
Vol. 259
813
R. Seifert, R. Burde and G. Schultz
uridine, PPi and TTP were obtained from Sigma
Chemie (Deisenhofen, Germany). All other nucleo-
tides were from Boehringer Mannheim (Mannheim,
Germany). Pertussis toxin was kindly provided by Dr
Motuyuki Yajima (Kyoto, Japan). Sources of other
materials and cell culture media have been described
elsewhere (Seifert et al., 1986, 1988; Seifert & Schultz,
1987a,b; Seifert & Schachtele, 1988).
Cell culture
HL-60 cells were grown in suspension culture in RPMI-
1640 medium supplemented with 1O 0 (v/v) horse serum,
1% (v/v) non-essential amino acids, 2 mM-L-glutamine,
50 U of penicillin/ml and 50 ,ug of streptomycin/ml in a
humidified atmosphere with 7 0 CO2 at 37 'C. To induce
differentiation, cells were seeded at a density of 106/ml
and were cultured for 48 h in the presence of 0.2 mm-
dibutyryl cyclic AMP or for 120 h in the presence of
160 mM-dimethyl sulphoxide (Chaplinski & Niedel, 1982;
Seifert & Schachtele, 1988). Cells were harvested by
centrifugation for 1O min at 250 g. Wright-Giemsa-
stained smears showed that > 95 Qo of the cells were
myelocytes or cells beyond this stage.
Preparation of human neutrophils
Heparinized blood was obtained by venous puncture
from healthy volunteers of either sex who had taken no
drugs for at least 3 weeks. Neutrophils were isolated
by dextran sedimentation and centrifugation through
Ficoll-Hypaque (Seifert & Schultz, 1987a). Cell
preparations contained more than 98 0 viable
neutrophils as judged by Trypan Blue dye exclusion.
Assay for 02- generation
NADPH oxidase-catalysed 02- generation was
monitored by continuous measurement of ferricyto-
chrome C reduction inhibitable by superoxide dismutase,
-5U,
0
0)
c.
E
-
E
01-
C
Lo61)0,
10
5
0
using a Uvikon 810 dual-beam spectrophotometer
(Kontron, Eching, Germany). Reaction mixtures (I ml)
contained 5 x 101 HL-60 cells or 2 x 106 neutrophils,
100 ,M-ferricytochrome C and a buffer consisting of:
138 mM-NaCl, 6 mM-KCl, 1 mM-MgCl2, l mM-CaCl2,
1 mM-Na2HP04, 5 mM-NaHCO3, 5.5 mM-glucose and
20 mM-Hepes, pH 7.4. Unless stated otherwise, all assays
were performed in the presence of cytochalasin B
(1 ,ug/ml). Reaction mixtures were preincubated at 37 °C
for 3 min. 02- generation was initiated by the addition of
the stimulus. The Vmax of 02- generation was calculated
from the linear sections of absorbance curves (Seifert &
Schachtele, 1988).
RESULTS
The effects of various purine nucleotides on NADPH
oxidase were studied in HL-60 cells differentiated with
dibutyryl cyclic AMP (Fig. 1). In the presence of
cytochalasin B, ATP activated NADPH oxidase with an
EC50of 5 ,iM and a maximum at 100 /M. The structure of
the polyphosphate chain of adenine nucleotides was
critical, as adenosine 5'-O-(l-thiotriphosphate), adenylyl
imidodiphosphate, cq,,-methylene-ATP and /,y-
methylene-ATP did not activate NADPH oxidase at
concentrations up to lO0 /M (results not shown). In
contrast, adenosine 5'-O-(3-thiotriphosphate) was as
potent as ATP. The length of the phosphate chain and the
substitution of the ribose moiety were also of importance,
as ADP and dATP were far less potent and efficient than
ATP. Pi, PPi, AMP and adenosine did not activate
NADPH oxidase at concentrations up to 100 /M (results
not shown). Furthermore, NADPH oxidase activation
by purine nucleotides exhibited base specificity. ITP was
less potent than ATP, and activated 02- generation with
an efficacy amounting to 60 0 of that of ATP. GTP, /,y-
methylene-GTP, guanosine 5'-O-(3-thiotriphosphate)
-log{[Nucleotide] (M)}
Fig. 1. Activation of NADPH oxidase by purine and pyrimidine nucleotides in HL-60 cells differentiated with dibutyryl cyclic AMP
(a) Concentration-response curves to purine nucleotides: *, ATP; *, adenosine 5'-O-(3-thiotriphosphate); *, dATP; V,
ADP; EJ, ITP. (b) Concentration-response curves to pyrimidine nucleotides: *, UTP; A, dUTP; V, UDP; A, TTP; 0I, CTP.
The open circles indicate that nucleotides at the indicated concentrations did not activate 02- formation. Nucleotides did not
affect cell viability as measured by Trypan Blue dye exclusion and release of lactate dehydrogenase. Data shown represent the
means of duplicate assays obtained with one preparation of HL-60 cells, which varied by less than 5 %. The variation in 02-
generation rates in ten experiments carried out with different batches of HL-60 cells was less than 10%.
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Fig. 2. Reversibility of NADPH oxidase activation in HL-60
cells differentiated with dibutyryl cyclic AMP
A indicates the addition of either 1,tM-fMet-Leu-Phe
(... 100 /IM-ATP (-- ) or 100 ,1M-UTP ( ). B marks
the addition of N-t-butoxycarbonyl-L-phenylalanyl-L-
leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine (10,UM) to
assays containing fMet-Leu-Phe (.. x ) or the addition of
hexokinase (20 units) to assays containing ATP ( --- x) or
UTP ( x ). Superimposed typical tracings of parallel
experiments are shown. Similar results were obtained in
four experiments carried out with different preparations of
HL-60 cells.
and guanylyl imidodiphosphate at concentrations up to
100,aM were inactive (results not shown). Among the
pyrimidine nucleotides, UTP activated NADPH oxidase
with a potency and an efficacy comparable to that of
ATP. dUTP, TTP, CTP and UDP were far less potent
and efficient activators of NADPH oxidase than was
UTP. UMP, uridine, uridyl(3'-5')uridine and UDP-
glucose were inactive at concentrations up to 100 /iM
(results not shown). Recently, a,,8-methylene-ATP has
been reported to be a partial antagonist at certain
purinoceptors (Katsuragi & Furukawa, 1985). However,
a,,l-methylene-ATP at a concentration of 100 /tM did not
prevent activation of 0°- formation by ATP or UTP at
a concentration of 10 /tM (results not shown). Similar
results as with ac,fl-methylene-ATP were obtained with
AMP and UMP.
Some characteristics ofNADPH oxidase activation by
UTP, ATP and fMet-Leu-Phe were compared (Fig. 2).
The efficacies of maximally stimulatory concentrations
ofATP and UTP to activate 0°- generation amounted to
30-50 0 of that of a maximally effective concentration of
fMet-Leu-Phe, with respect both to Vmax and to the
absolute amount of 02- generated. In addition,
nucleotides and chemotactic peptides reversibly activated
02- formation which ceased after 8-15 min. In agreement
with a recent report (Korchak et al., 1984), NADPH
oxidase activation by fMet-Leu-Phe was rapidly
terminated upon addition of a 10-fold excess of
its competitive antagonist, N-t-butoxycarbonyl-L-
phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenyl-
alanine, suggesting that the continuous occupation
of formyl peptide receptors by agonist is required to
maintain 0°- formation. As no competitive antagonists
for ATP and UTP were available, we used hexokinase
reactions to remove the nucleotides from the reaction
mixtures. Hexokinase catalyses the phosphorylation of
glucose and, thereby, the dephosphorylation of ATP to
ADP. Yeast hexokinase rapidly terminated 02- gener-
ation induced by ATP and gradually inhibited that
induced by UTP, corresponding to the findings that ATP
is a much better substrate for yeast hexokinase than is
UTP (Colowick, 1973), and that both ADP and UDP are
not efficient activators of 02- formation. Thus, the
continuous presence of ATP and UTP was essential to
maintain 02- formation. In addition to reversibility,
activation of NADPH oxidase by fMet-Leu-Phe and
nucleotides depended on the presence ofextracellular Ca2+
(1 mM). In the absence of free Ca2 , these stimuli did not
activate 02- formation. Mg2+ (1 mM) was no substitute
for Ca2' and did not enhance 02- formation in the
presence of Ca2+ (results not shown).
In order to elucidate the role of G proteins in NADPH
oxidase activation by extracellular nucleotides, HL-60
cells were treated with pertussis toxin. Pertussis toxin
inhibited in a concentration-dependent fashion, acti-
vation of NADPH oxidase by fMet-Leu-Phe, ATP and
UTP but not by phorbol myristate acetate, which
circumvents receptor stimulation by directly activating
protein kinase C (Fig. 3). The inhibitory effect of pertussis
toxin on the fMet-Leu-Phe- and UTP-induced 02-
generations was half-maximal at 10 ng/ml and was
maximal at 100 ng/ml. In contrast to its effects on
NADPH oxidase activation by fMet-Leu-Phe and UTP,
pertussis toxin inhibited the ATP-induced 02- generation
only by up to 600. The effect of pertussis toxin on 02-
formation was time-dependent. Half-maximal inhibition
of 02- generation was observed after 30-45 min of toxin
treatment. Inhibition of the fMet-Leu-Phe- and UTP-
induced 02- generation was complete after an incubation
time of 2 h. In contrast, treatment of the cells with
pertussis toxin for up to 3 h did not completely suppress
the stimulatory effect of ATP. These results indicate that
UTP and ATP did not activate NADPH oxidase by
similar mechanisms.
The repeated exposure of human neutrophils to hor-
monal agonists desensitizes the cells to generating 02-
upon restimulation (Smith et al., 1984). Therefore,
desensitization experiments were performed in HL-60
cells. Cells were pretreated with fMet-Leu-Phe, ATP or
UTP at maximally stimulatory concentrations, and 02-
generation upon re-exposure to these agents was
measured (Table 1). Pretreatment of the cells with fMet-
Leu-Phe desensitized 02- generation upon re-exposure to
the chemotactic peptide but not to ATP or UTP.
Conversely, pretreatment with ATP or UTP did not
desensitize the cells towards fMet-Leu-Phe but did
desensitize them towards both ATP and UTP, a
phenomenon known as heterologous desensitization
(Smith et al., 1984).
These results prompted us to study the interaction of
chemotactic peptides and nucleotides on 02 formation
in HL-60 cells differentiated with dibutyryl cyclic AMP
or dimethyl sulphoxide and in human neutrophils. The
experiments depicted in Fig. 4 were carried out in the
absence of cytochalasin B, which enhances fMet-
Leu-Phe-induced 02- generation by inhibiting receptor
sequestration and by expressing new receptors (Jesaitis
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Fig. 3. Inhibition of 02- formation by pertussis toxin in HL-60 cells differentiated with dibutyryl cyclic AMP
HL-60 cells were suspended in culture medium at a concentration of 2 x 106 cells/ml and incubated in the presence of pertussis
toxin or its carrier. Cell viability after incubation with pertussis toxin was > 95 % as revealed by Trypan Blue dye exclusion.
Following toxin treatment, cells were harvested and assayed for 02- formation. (a) Concentration-dependence. Cells were
incubated for 3 h in the presence of the indicated concentrations of toxin. (b) Time-dependence. Cells were incubated in the
presence of pertussis toxin (100 ng/ml) for the indicated periods of time. The concentrations of stimuli for determination of 02-
generation were as follows: O, 100 ng of phorbol myristate acetate/ml; *, 1 /LM-fMet-Leu-Phe; A, 100 /iM-ATP; *, 100 /LM-
UTP. Data shown represent means of assay duplicates obtained with one batch of HL-60 cells which varied by less than 5 %.
Similar results were obtained in three experiments carried out with different preparations of HL-60 cells which varied by less
than 10%.
et al., 1986). In the absence of cytochalasin B, dibutyryl
cyclic AMP-differentiated HL-60 cells generated 0°- at
rates amounting to 30-60 o of those in the presence of
cytochalasin B upon exposure to UTP (100 JM) and
fMet-Leu-Phe (1 /aM) (see Figs. 1, 3 and 4). UTP and
ATP at concentrations of up to 10 /M did not activate
NADPH oxidase in the absence of cytochalasin B. UTP
Table 1. Desensitization of 02- generation in HL-60 cells
differentiated with dibutyryl cyclic AMP
HL-60 cells were harvested, suspended at a density of
2 x 107 cells/ml in buffer for determination of 02- gener-
ation and incubated for 10 min in the presence of buffer
(control), fMet-Leu-Phe, ATP or UTP at the indicated
concentrations at 37 'C. Thereafter, stimuli were diluted
by suspending the cells in a 10-fold excess of volume of
buffer not supplemented with CaCI2 and stimulus. Cells
were harvested and assayed for 02- generation with various
stimuli. The means of three experiments performed with
different preparations of HL-60 cells are given; these
varied by less than 100%.
02- generation (% of control)
Stimulus... fMet-Leu-Phe ATP UTP
Treatment (1 'eM) (100 /M) (100 pM)
fMet-Leu-Phe (1 /tM)
ATP (100 ,UM)
UTP (100 /uM)
20
93
101
106
42
18
93
20
26
(0.1-10 /M) enhanced in a concentration-dependent
manner 02- generation induced by fMet-Leu-Phe at
submaximally and maximally stimulatory concentrations
by up to 8-fold. In addition, UTP made the cells
responsive to a non-stimulatory concentration of fMet-
Leu-Phe (1 nM), a process called priming (McPhail &
Snyderman, 1984; Rossi, 1986). Similar results were
obtained with ATP as with UTP. Upon exposure to
fMet-Leu-Phe, dimethyl sulphoxide-differentiated HL-
60 cells generated 02- at much lower rates than dibutyryl
cyclic AMP-differentiated cells (Table 2). This finding is
in agreement with a previous report showing that di-
butyryl cyclic AMP-differentiated cells expressed much
higher numbers offormyl peptide receptors than dimethyl
sulphoxide-differentiated cells (Chaplinski & Niedel,
1982). In dimethyl sulphoxide-differentiated HL-60 cells,
nucleotides at concentrations up to 100 /M did not
activate NADPH oxidase. However, ATP and UTP
potentiated fMet-Leu-Phe-induced 2- generation. By
analogy to dimethyl sulphoxide-differentiated HL-60
cells, nucleotides per se failed to activate NADPH oxidase
in human neutrophils. In the absence of cytochalasin B,
UTP enhanced the effect of fMet-Leu-Phe in neutrophils
by 3-fold, whereas in the presence of cytochalasin B,
UTP stimulated 02- formation only by 42%.
In human neutrophils, the effects of fMet-Leu-Phe are
inhibited by activators of adenylate cyclase, such as
5'-N-ethylcarboxamidoadenosine, isoproterenol, prosta-
glandin E1 and cholera toxin (Bokoch & Gilman, 1984;
Lad et al., 1985b; Cronstein et al., 1985; Gryglewski
et al., 1987). Furthermore, these agents differentially
inhibit 02- formation induced by different classes of
1989
816
Activation of NADPH oxidase by purine and pyrimidine nucleotides
30
1-(,
zC.,
0
0
a 20-
E
-
C
0
, 10~
E
c
-
c
0)
0
0 l
00 9 8 7 6
-log{[fMet-Leu-Phe] (M)}
Fig. 4. Synergistic activation ofNADPH oxidase by nucleotides
and chemotactic peptides in HL-60 cells differentiated
with dibutyryl cyclic AMP
The effects of various concentrations of fMet-Leu-Phe
were studied in the presence of one fixed concentration of
ATP and four fixed concentrations of UTP. Nucleotides
and fMet-Leu-Phe were added simultaneously to reaction
mixtures. *, Buffer (control); El, 10 1M-ATP; A, 0.1 ,UM-
UTP;. *, I ,uM-UTP; 7, IO tsM-UTP; *, 100,aM-UTP.
Assays were carried out in the absence of cytochalasin B.
Data shown represent the means of assay duplicates
obtained with one preparation of HL-60 cells, which
varied by less than 5 %. Similar results were obtained in
five experiments carried out with different batches of
HL-60 cells, which varied by less than 100%.
Table 2. Synergistic activation of NADPH oxidase by
nucleotides and chemotactic peptides in HL-60 cells
differentiated with dimethyl sulphoxide and in human
neutrophils: effect of cytochalasin B
Activation of 02- formation by fMet-Leu-Phe, ATP-, UTP
and combinations of these stimuli as well as the inter-
action with cytochalasin B (CB) were studied in dimethyl
sulphoxide-differentiated HL-60 cells and in human
neutrophils. The concentrations of stimuli were I ,UM
(fMet-Leu-Phe), 10 /LM (ATP and UTP) and 1 ,ug/ml (CB).
The means+S.E.M. of assay triplicates are shown. Similar
results were obtained with three batches of HL-60 cells
and with neutrophils from five different donors which
varied less than 10%. n.d., not done.
2- generation(nmol/min per 107 cells)
Human
Stimulus Cell line... HL-60 cells neutrophils
fMet-Leu-Phe
ATP
UTP
fMet-Leu-Phe +ATP
fMet-Leu-Phe + UTP
fMet-Leu-Phe +CB
UTP
fMet-Leu-Phe + UTP + CB
2.7 +0.3
0
0
5.0 +0.4
5.1 +0.2
n.d.
0
n.d.
5.3 +0.2
0
0
15.3+ 1.0
15.8 +0.8
32.0+ 1.6
0
45.5 +4.0
Table 3. Inhibition of 02- formation by various activators of
adenylate cyclase in HL-60 cells differentiated with
dibutyryl cyclic AMP
HL-60 cells were cultured for 48 h in the presence of
0.2 mM-dibutyryl cyclic AMP to induce expression of
formyl peptide and nucleotide receptors. Thereafter, cells
were harvested and suspended in the buffer for 02-
generation containing no dibutyryl cyclic AMP. The
activators of adenylate cyclase, 5'-N-ethylcarboxamido-
adenosine (NECA), isoproterenol, prostaglandin E1 or
buffer (control) were added to reaction mixtures at the
indicated concentrations 3 min prior to fMet-Leu-Phe,
ATP or UTP. Cells were treated with cholera toxin or its
carrier (control) for 2 h according to the procedure de-
scribed in the legend to Fig. 3. Data shown represent the
means of four to seven experiments carried out with
different preparations of HL-60 cells which varied less
than I0O.
2- generation (% of control)
Stimulus ... fMet-Leu-Phe ATP UTP
Treatment (1 aM) (100 ItM) (100 ,tM)
NECA (10/tM) 66 85 53
Isoproterenol (I /M) 90 98 76
Prostaglandin E1 (10 tM) 89 92 55
Cholera toxin (1,g/ml) 36 92 30
hormone agonist. In preliminary experiments, the
concentrations of adenylate cyclase activators given
in Table 3 were found to be maximally inhibitory on
02- formation (results not shown). In dibutyryl cyclic
AMP-differentiated HL-60 cells, 5'-N-ethylcarboxamido-
adenosine inhibited the effects of maximally stimu-
latory concentrations of fMet-Leu-Phe and UTP by 33
and 4700 respectively, whereas the effect of ATP was
inhibited by only 15 %. ?soproterenol and prostaglandin
E1 inhibited fMet-Leu-Phe- and ATP-induced 02-
formation by < 10% and UTP-induced 02- formation
by up to 45 %. Pretreatment of the cells with cholera
toxin reduced the effects of fMet-Leu-Phe and UTP by
up to 70 %, whereas the effect of ATP on NADPH
oxidase was almost unaffected.
DISCUSSION
As pertussis toxin inhibits the effects of ATP and UTP
on NADPH oxidase, and as activation of 02- formation
exhibits a high degree of specificity for relatively few
purine and pyrimidine nucleotides, it is likely that the
effects of nucleotides are receptor-mediated. In addition,
ATP and UTP activate 02- formation at concentrations
required to activate other cellular functions presumably
occurring in vivo (Gordon, 1986). Furthermore, NADPH
oxidase activations by ATP, UTP and fMet-Leu-Phe
have several characteristics in common, i.e. dependence
on extracellular Ca2+, reversibility, requirement for con-
tinuous presence of agonist, desensitization, augmen-
tation by cytochalasin B and inhibition by activators of
adenylate cyclase.
In agreement with previous reports, we found that
ATP and adenosine 5'-O-(3-thiotriphosphate) are potent
purinergic agonists in HL-60 cells (Dubyak et al., 1987;
Cowen et al., 1988). Interaction of purinoceptors with
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pertussis toxin-sensitive G proteins has been documented
only for inhibition of adenylate cyclase in rat hepatocytes
but not for activation of a purinergic effector system, i.e.
phospholipase C (Okajima et al., 1987). Thus, the per-
tussis toxin sensitivity of NADPH oxidase activation by
purinergic agonists is a novel feature of purinoceptors. In
addition, the purinoceptors in HL-60 cells show some
further properties which are different from those of other
purinoceptors. In platelets, ADP is the most potent
agonist, and in mast cells only ATP acts as an agonist
at purinoceptors (Gordon, 1986). Furthermore, a,,J-
methylene-ATP and /,y-methylene-ATP are P2X-
purinoceptor agonists but are not activators of NADPH
oxidase (Burnstock & Kennedy, 1985). Finally, adenylyl
imidodiphosphate is an agonist at P2,-purinoceptors but
not at purinoceptors of HL-60 cells (Rice & Singleton,
1987). These data suggest that the purinoceptors in
HL-60 cells do not belong to hitherto characterized
purinoceptor subtypes.
In human neutrophils, pertussis toxin and activators
of adenylate cyclase differentially inhibit O2- formation
induced by various classes of hormonal agonists (Lad
et-al., 1985a; Gryglewski et al., 1987; Verghese et al.,
1987; Shirato et al., 1988). NADPH oxidase activation by
UTP in HL-60 cells is more sensitive towards inhibition
by pertussis toxin and activators ofadenylate cyclase than
that induced by ATP. These data clearly indicate that
UTP does not mediate its effects via purinoceptors. The
results strongly support recent data suggesting the
existence of pyrimidinoceptors (Kuigelen et al., 1987;
Haussinger et al., 1987), which, at least in the case of HL-
60 cells, interact with pertussis toxin-sensitive G proteins.
UTP appears to be the endogenous ligand for this
pyrimidinoceptor, as other pyrimidine nucleotides are
far less effective activators of 02- formation. Activation
of NADPH oxidase by pyrimidine nucleotides shows a
nucleotide specificity different from that for the activation
of other cellular systems, suggesting heterogeneity among
pyrimidinoceptors (Shirasawa -et al., 1983; Hardebo
et al., 1987; Kiigelen et al., 1987; Haussinger et al., 1987).
UTP and ATP both potentiate 2- formation induced
by chemotactic peptides even with both classes of stimuli
present at maximally stimulatory concentrations, indi-
cating that these agents activate NADPH oxidase via
different receptors. Agonists acting via distinct receptors
may additively activate G proteins, and thus may greatly
amplify activation of effector systems, i.e. NADPH
oxidase and/or phospholipase C. In addition, occupation
of purino- and pyrimidinoceptors with agonists may
increase the number and/or affinity state of formyl
peptide receptors or may prevent their sequestration.
The latter possibilities are supported by the finding that
-cytochalasin B diminishes the potentiating effect of UTP,
indicating that both agents act, at least in part, by a
mechanism they have in common (Jesaitis et al., 1.986).
In contrast to dibutyryl cyclic AMP-differentiated cells,
ATP and UTP do not activate NADPH oxidase in
dimethyl sulphoxide-differentiated HL-60 cells and in
human neutrophils, but they do potentiate 2- formation
induced by fMet-Leu-Phe. Nucleotides are released into
the extracellular space under various physiological and
pathological conditions (Goetz et al., 1971; Shirasawa
et al., 1983; Gordon, 1986; Forsberg et al., 1987;
Hardebo et al., 1987). Thus, ATP and UTP may play roles
as intercellular signal molecules in the regulation of 02
formation. The physiological function of nucleotides
apparently is to potentiate NADPH oxidase activation
rather than to activate the enzyme per se. As ATP and
UTP per se lead to activation of NADPH oxidase in
dibutyryl cyclic AMP-differentiated HL-60 cells, possibly
due to the expression of very high numbers of purino-
and pyrimidinoceptors, these cells provide a useful model
system to study purinergic and pyrimidinergic activation
of NADPH oxidase.
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